RxDoctor Payments Data

Matthew Marino, MD

Otolaryngology · Chesterfield, MONPI 1639497829

Payments from drug & device makers

What this record shows

14 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 32.3% of the total. Reporting peaked in 2019 at $5,074 and has fallen 85.7% since, to $724 in 2025. Among otolaryngology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,215in general payments, 2019–2025

Across 92 payments — averaging $111.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$3K
  • Intersect ENT, Inc.$3K
  • Stryker$2K
  • Sanofi$681
  • GSK$344
  • Optinose US, Inc.$166
  • plus $715 from 8 others

What the payments were for

  • Travel & lodging$4,82247%
  • Food & beverage$5,39353%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,215 in reported general payments places this provider in the 90th percentile of 210 otolaryngology providers in Missouri.

See all otolaryngology providers in Missouri

Medicare billing

Part B allowed, 2024
$182,073
Medicare patients
620
Services billed
3,499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide167$3,391
Azelastine Hcl114$3,067
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth33$2,458
Omeprazole75$1,057
Fluticasone Propionate48$995
Famotidine30$552
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav37$327
Esomeprazole Magnesium14$299
Montelukast Sodium18$221
Methylprednisolone37$214
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$207
Doxycycline Hyclate16$156
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip19$155
Prednisone51$148
Mupirocin17$90

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Chesterfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →